Amgen bought Ch...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Urent electric scooters appeared in Yandex Go
4/26/23
YNDX
Whoosh reported for 2022 according to IFRS
4/26/23
WUSH
Microsoft reported for 9 months of fiscal year 2023
4/26/23
MSFT
Visa reported for 6 months of fiscal year 2023
4/26/23
V
Alphabet reported for 3 months of 2023
4/26/23
GOOG
Uniper's stake in Unipro transferred to Rosimuschestvo for temporary management
4/26/23
UPRO
TMK's RAS profit nearly doubled in 2022
4/26/23
TRMK
Rosimushchestvo received Fortum's stake in TGC-1 under temporary management
4/25/23
TGKA
Genetico completes IPO offering
4/25/23
GECO
The International Business Machines announced a quarterly dividend
4/25/23
IBM
«
Previous
641
642
643
644
645
646
647
648
649
650
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)